NURS 6501 Week 9 Assignment; MindMap - Generalized Anxiety Disorder

2 Mind Map: Generalized Anxiety Disorder Generalized Anxiety Disorder (GAD) is a chronic psychiatric condition characterized by excessive and uncontrollable worry across multiple domains of life. According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), GAD involves persistent anxiety and worry occurring more days than not for at least six months and is associated with at least three of the following symptoms in adults: restlessness or feeling keyed up, being easily fatigued, difficulty concentrating, irritability, muscle tension, and sleep disturbances (American Psychiatric Association [APA], 2022). Pathophysiology and Etiology The pathophysiology of GAD is multifactorial, involving alterations in brain structure, neurotransmitter imbalances, and neuroendocrine dysregulation. Specifically, the amygdala, hippocampus, and prefrontal cortex dysfunctions contribute to impaired fear regulation and emotional processing. Neurochemical disturbances, particularly reduced gamma-aminobutyric acid (GABA) activity, and altered serotonergic, dopaminergic, and noradrenergic transmission, underlie the sustained arousal and anxiety symptoms experienced by patients (Rogers, 2023). Chronic activation of the hypothalamic-pituitary-adrenal (HPA) axis in response to stress results in elevated cortisol levels, further exacerbating anxiety symptoms and impairing feedback mechanisms that regulate stress responses (Tafet & Nemeroff, 2020). Etiologically, GAD arises from a combination of genetic and environmental influences. Twin studies suggest heritability estimates between 30% and 50%. Environmental risk factors include childhood adversity, trauma, overprotective or neglectful parenting styles, and chronic 4 bowel syndrome. Chronic stress and cortisol elevation impact endocrine functioning, contributing to insulin resistance and increased appetite. The immune system may be suppressed over time, reducing host defenses and increasing susceptibility to infections. These systemic effects highlight the importance of recognizing anxiety as a biopsychosocial condition (Rogers, 2023). Complications Untreated or poorly managed GAD can lead to significant complications. These include the development of major depressive disorder, panic disorder, substance use disorders, and increased risk of suicide. Prolonged stress may exacerbate preexisting medical conditions such as cardiovascular disease, metabolic syndrome, and gastrointestinal disorders. Cognitive function may also decline due to chronic stress, affecting memory, attention, and executive functioning. Social isolation, occupational impairment, and reduced quality of life are common long-term consequences (Cheng, & Freemantle, 2019). Diagnostic Tests and Labs The diagnostic process for GAD begins with a comprehensive clinical interview based on DSM-5-TR criteria. Screening tools such as the Generalized Anxiety Disorder-7 (GAD-7) scale are frequently used to quantify symptom severity. The Hamilton Anxiety Rating Scale (HAM- A), a clinician-administered instrument, evaluates psychic and somatic symptoms and is widely utilized in research and clinical practice (Hamilton, 1959). Laboratory tests conducted to exclude medical conditions that may mimic anxiety include thyroid function tests (TSH and free T4) to rule out hyperthyroidism, complete blood count (CBC) to assess for anemia or infection, 6 References American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.; DSM-5-TR). https://doi.org/10.1176/appi.books.9780890425787 Cheng, Z., & Freemantle, N. (2019). Pharmacological treatments for generalized anxiety disorder: A systematic review and network meta-anaylsis. The Lancet Psychiatry, 393(10173), 768– 777. https://doi.org/10.1016/S0140-6736(18)31793-8 Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32(1),